NTRB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nutriband Inc (NTRB) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to support immediate investment. Holding off for better entry points or improved fundamentals is recommended.
The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, RSI is neutral at 41.684, and moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level (3.734) with resistance at 3.986 and support at 3.482.
The company has selected a brand name for its abuse-resistant fentanyl patch and plans to submit it to the FDA for approval, which could be a future catalyst.
The stock is expected to decline in the short term with a 90% chance of -2.3% in the next day, -1.66% in the next week, and -10.8% in the next month. Additionally, hedge funds and insiders are neutral, and there are no significant trading trends.
In Q3 2026, revenue dropped significantly by -46.41% YoY to $346,058. Net income improved but remains negative at -$3,872,367 (up 184.18% YoY). EPS increased to -0.32 (up 166.67% YoY), and gross margin dropped to 19.8%, down -33.06% YoY. Overall, the financial performance is weak.
No analyst rating or price target changes are available for this stock.
